KIDINS220 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.56570000087575E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.53810000291799E-08 |
Normal-vs-Stage2 |
2.788000E-04 |
Normal-vs-Stage3 |
3.36759999997049E-06 |
Normal-vs-Stage4 |
3.55610000002393E-06 |
Stage1-vs-Stage2 |
6.751800E-01 |
Stage1-vs-Stage3 |
9.944200E-01 |
Stage1-vs-Stage4 |
2.057600E-01 |
Stage2-vs-Stage3 |
6.743800E-01 |
Stage2-vs-Stage4 |
1.371570E-01 |
Stage3-vs-Stage4 |
1.767990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.41069999810051E-08 |
Normal-vs-AfricanAmerican |
3.11829999999347E-06 |
Normal-vs-Asian |
5.238900E-03 |
Caucasian-vs-AfricanAmerican |
9.127000E-01 |
Caucasian-vs-Asian |
9.502800E-01 |
AfricanAmerican-vs-Asian |
9.795600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.73120001562199E-09 |
Normal-vs-Female |
3.999400E-03 |
Male-vs-Female |
4.724200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
8.16040000017892E-07 |
Normal-vs-Extreme_Weight |
4.72110017746274E-10 |
Normal-vs-Obese |
2.02619999999376E-05 |
Normal-vs-Extreme_Obese |
3.842400E-03 |
Normal_Weight-vs-Extreme_Weight |
6.682600E-01 |
Normal_Weight-vs-Obese |
1.848160E-01 |
Normal_Weight-vs-Extreme_Obese |
5.500400E-01 |
Extreme_Weight-vs-Obese |
3.298200E-02 |
Extreme_Weight-vs-Extreme_Obese |
3.410400E-01 |
Obese-vs-Extreme_Obese |
8.796800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.241000E-01 |
Normal-vs-Age(41-60Yrs) |
3.87490000000046E-05 |
Normal-vs-Age(61-80Yrs) |
4.32940017169869E-10 |
Normal-vs-Age(81-100Yrs) |
2.26019999999272E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.649200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.723400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.608760E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.600900E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.560010E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.878000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.05909999992271E-07 |
Normal-VS-Type2 PRCC |
1.46719999483125E-08 |
Normal-VS-KIRP CIMP |
1.057100E-03 |
Normal-VS-Unclassified PRCC |
3.430400E-01 |
Type1 PRCC-VS-Type2 PRCC |
4.014100E-02 |
Type1 PRCC-VS-KIRP CIMP |
7.250400E-01 |
Type1 PRCC-VS-Unclassified PRCC |
1.195840E-01 |
Type2 PRCC-VS-KIRP CIMP |
5.868200E-01 |
Type2 PRCC-VS-Unclassified PRCC |
2.190100E-02 |
KIRP CIMP-VS-Unclassified PRCC |
1.555170E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.46509999999911E-05 |
Normal-vs-N1 |
3.182600E-04 |
Normal-vs-N2 |
3.697000E-03 |
N0-vs-N1 |
6.720600E-01 |
N0-vs-N2 |
7.922200E-01 |
N1-vs-N2 |
5.369400E-01 |
|
|